Evidence and Practices in the Use of Uncooked Cornstarch and Glycosade in GSD, Creating a Glycogen Storage Disease Program

Evidence and Practices in the Use of Uncooked Cornstarch and Glycosade in GSD (segment 1)

We invite you to join our speaker Dr. David Weinstein of the University of Florida Glycogen Storage Disease Program, as he describes the use of uncooked cornstarch and Glycosade in treating GSD patients.

By participating in this presentation, participants will be able to:

• Explain the history of cornstartch use and compare with continuous glucose therapy
• Describe The University of Florida’s approach to dosing cornstarch
• Describe new data on the long term outcome in people treated with cornstarch
• Discuss advances in the cornstarch field (Glycosade)

Creating a Glycogen Storage Disease Program (segment 2)

Join our speaker Dr. Laurie Tsilianidis, M.D. as she explains the process of setting up a Glycogen Storage Disease Program at the Cleveland Clinic

Participants of this presentation will:

• Gain an understanding of how to develop an inpatient protocol for the initiation of Glycosade
• Develop Practical strategies for patient selection, dosing, monitoring and follow up